QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$45.40 USD
-0.83 (-1.80%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $45.44 +0.04 (0.09%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum C VGM
Cash flow Statements
Fiscal Year End for QuidelOrtho Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -10.10 | 548.70 | 704.23 | 810.29 | 72.92 |
Depreciation/Amortization & Depletion | 457.20 | 273.20 | 59.27 | 56.43 | 61.60 |
Net Change from Assets/Liabilities | -194.90 | -34.80 | 0.23 | -250.63 | -15.24 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 28.00 | 98.20 | 42.14 | 13.68 | 15.21 |
Net Cash From Operating Activities | 280.20 | 885.30 | 805.87 | 629.76 | 134.49 |
Property & Equipment | -209.30 | -140.90 | -292.72 | -64.93 | -27.23 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -1,511.40 | 0.00 | 0.00 | 0.00 |
Investments | 18.20 | -10.30 | -63.69 | 0.00 | 0.00 |
Other Investing Activities | 3.50 | 18.40 | 36.88 | 1.61 | 0.00 |
Net Cash from Investing Activities | -187.60 | -1,644.20 | -319.53 | -63.32 | -27.23 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.40 | -47.90 | -95.89 | -38.28 | 4.05 |
Issuance (Repayment) of Debt | -228.00 | 346.20 | -0.26 | -43.96 | -53.56 |
Increase (Decrease) Short-Term Debt | 1.60 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -43.80 | -46.30 | -77.03 | -48.04 | -48.78 |
Net Cash from Financing Activities | -265.80 | 252.00 | -173.18 | -130.28 | -98.28 |
Effect of Exchange Rate Changes | -1.20 | -2.00 | -0.35 | 1.00 | 0.11 |
Net Change In Cash & Equivalents | -174.40 | -508.90 | 312.81 | 437.17 | 9.08 |
Cash at Beginning of Period | 293.90 | 802.80 | 489.94 | 52.78 | 43.70 |
Cash at End of Period | 119.50 | 293.90 | 802.75 | 489.94 | 52.78 |
Diluted Net EPS | -0.15 | 9.56 | 16.43 | 18.60 | 1.73 |
Fiscal Year End for QuidelOrtho Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -1,853.70 | -1,706.00 | -10.10 | -17.10 | -4.40 |
Depreciation/Amortization & Depletion | 1,974.90 | 1,858.80 | 457.20 | 341.80 | 228.70 |
Net Change from Assets/Liabilities | -215.90 | -86.10 | -194.90 | -149.60 | -80.80 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -3.90 | -67.40 | 28.00 | 24.70 | 14.80 |
Net Cash From Operating Activities | -98.60 | -0.70 | 280.20 | 199.80 | 158.30 |
Property & Equipment | -101.40 | -66.10 | -209.30 | -160.70 | -117.30 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 55.90 | 55.90 | 18.20 | 17.70 | 3.30 |
Other Investing Activities | -10.00 | -10.00 | 3.50 | 10.50 | 2.80 |
Net Cash from Investing Activities | -55.50 | -20.20 | -187.60 | -132.50 | -111.20 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.60 | 0.50 | 4.40 | 8.10 | 7.30 |
Issuance (Repayment) of Debt | -103.70 | -11.90 | -228.00 | -175.70 | -123.80 |
Increase (Decrease) Short-Term Debt | 251.40 | -1.30 | 1.60 | 2.90 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -8.30 | -5.80 | -43.80 | -43.30 | -42.80 |
Net Cash from Financing Activities | 144.00 | -18.50 | -265.80 | -208.00 | -159.30 |
Effect of Exchange Rate Changes | -1.90 | -1.10 | -1.20 | -3.30 | -2.10 |
Net Change In Cash & Equivalents | -12.00 | -40.50 | -174.40 | -144.00 | -114.30 |
Cash at Beginning of Period | 119.50 | 119.50 | 293.90 | 293.90 | 293.90 |
Cash at End of Period | 107.50 | 79.00 | 119.50 | 149.90 | 179.60 |
Diluted Net EPS | -2.20 | -25.50 | 0.11 | -0.19 | -0.80 |